1Cooper DS, Doherty GM, Haugen BR, et al. Management guide - lines for patientswith thyroid nodules and differentiated thyroid cancer[J]. Thyroid,2006,16(2) :109 - 114.
2Kim E, Park JS, Son KR, et 81. Preoperative diagnosis of cervical metastatic lymph nodes in papillary thyroid carcinoma: comparison of ultrasound, computed tomography, and combined ultrasound with computed tomography[J]. Thyroid,2008, 18(4) :411 -418.
3Sawin CT, Geller A, Wolf PA,et al. Low serum thyrotropin concen- trations as a risk factor for atrial fibrillation in older persons[J]. N Engl J Med,1994,33(19) : 1249 - 1252.
7Ahn JE, Lee JH, Yi JS, et al. Diagnostic accuracy of CT and ultra- sonography for evaluating metastatic cervical lymph nodes in pa- ticntswith thyroid cancer[ J ]. World J Surg, 2008,32 (7) : 1552 - 1558.
5Hodgson NC, Button J, Solorzano CC. Thyroid cancer: is the incidence still increasing[J] ? Ann Surg Oncol, 2004, 11( 12): 1093 - 1097.
6Sciuto R, Romano L, Marandino F, et al. Natural history and clinical outcome of differentiated thyroid carcinoma: a retrospective analysis of 1503 patients treated at a single institution[J]. Ann One, 2009, 20(10) : 1728 - 1735.
7Eustatia-Rutten CF, Corssmit EP, Biermasz NR, et al. Survival and death causes in differentiated thyroid carcinoma[J]. J Clin Endocrinol Metab, 2006, 91(1) : 313 -319.
8Baudin E, Schlumberger M. New therapeutic approachea for metastatic thyroid carcinoma [ ] ]. Lancet Oncol, 2007, 8 (2) : 148 - 156.
9Durante C, Haddy N, Baudin E, et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy [ J]. J Clin Endocrinol Metab, 2006, 91 (8) : 2892 - 2899.
10Mazzaferri EL, Jhiang SM, Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer[ J]. Am J Med, 1994, 97(5) : 418 -428.
